CVS:NYE-CVS Health Corp (USD)

COMMON STOCK | Healthcare Plans |

Last Closing

USD 58.08

Change

+0.51 (+0.89)%

Market Cap

N/A

Volume

7.81M

Analyst Target

USD 78.78
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-24 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

+1.78 (+0.31%)

USD 532.88B
ELV Elevance Health Inc

-6.55 (-1.23%)

USD 125.09B
CNC Centene Corp

-0.95 (-1.26%)

USD 39.78B
MOH Molina Healthcare Inc

-1.69 (-0.49%)

USD 20.81B
OSCR Oscar Health Inc

-0.62 (-2.78%)

USD 5.30B
NEUE NeueHealth Inc

-0.02 (-0.39%)

USD 0.05B
CI Cigna Corp

-1.77 (-0.50%)

N/A
HUM Humana Inc

-0.54 (-0.17%)

N/A

ETFs Containing CVS

WBIY WBI Power Factor® High D.. 4.71 % 0.70 %

+0.21 (+-0.15%)

USD 0.06B
LUSC:LSE SPDR Barclays 10+ U.S. Co.. 0.43 % 0.00 %

+0.06 (+-0.15%)

N/A
LCRP:LSE SPDR Barclays 10+ U.S. Co.. 0.42 % 0.00 %

-0.02 (-0.15%)

USD 0.09B
SUSC:LSE SPDR Barclays 0-3 Year US.. 0.41 % 0.00 %

+0.04 (+-0.15%)

N/A
SYBN:F SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

+0.03 (+-0.15%)

USD 0.10B
SYBN:XETRA SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

N/A

USD 0.10B
SYBR:F SSgA SPDR ETFs Europe I P.. 0.30 % 0.00 %

-0.05 (-0.15%)

USD 0.23B
SYBR:XETRA SPDR Barclays 3-10 U.S. C.. 0.30 % 0.00 %

-0.02 (-0.15%)

USD 0.23B
IUCB:SW SPDR® Bloomberg 1-10 Yea.. 0.30 % 0.00 %

-0.05 (-0.15%)

USD 0.31B
AGGY WisdomTree Yield Enhanced.. 0.00 % 0.12 %

+0.05 (+-0.15%)

USD 0.99B
BSCP Invesco BulletShares 2025.. 0.00 % 0.10 %

+0.01 (+-0.15%)

N/A
ESGF 0.00 % 0.40 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

+0.16 (+-0.15%)

USD 0.07B
IBDL 0.00 % 0.10 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

-0.19 (-0.15%)

N/A
ILTB iShares Core 10+ Year USD.. 0.00 % 0.06 %

+0.07 (+-0.15%)

USD 0.65B
LQD iShares iBoxx $ Investmen.. 0.00 % 0.15 %

+0.19 (+-0.15%)

N/A
SPLB SPDR Barclays Long Term C.. 0.00 % 0.08 %

+0.05 (+-0.15%)

USD 1.03B
IG Principal Exchange-Traded.. 0.00 % 0.26 %

+0.03 (+-0.15%)

USD 0.09B
IGLB iShares 10+ Year Investme.. 0.00 % 0.10 %

+0.10 (+-0.15%)

USD 2.87B
IBDT iShares iBonds Dec 2028 T.. 0.00 % 0.10 %

+0.02 (+-0.15%)

USD 2.22B
RTH VanEck Retail ETF 0.00 % 0.35 %

+1.65 (+-0.15%)

N/A
RWL Invesco S&P 500 Revenue E.. 0.00 % 0.39 %

-0.09 (-0.15%)

N/A
SLQD iShares 0-5 Year Investme.. 0.00 % 0.06 %

+0.01 (+-0.15%)

USD 2.09B
SPVU Invesco S&P 500® Enhance.. 0.00 % 0.16 %

-0.12 (-0.15%)

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

-0.03 (-0.15%)

N/A
ICAN 0.00 % 0.50 %

N/A

N/A
UC84:LSE UBS Barclays US Liquid Co.. 0.00 % 0.00 %

-0.50 (-0.15%)

USD 0.09B
VVAL:LSE 0.00 % 0.00 %

N/A

N/A
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
GBLO 0.00 % 0.00 %

N/A

N/A
NVQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -26.44% 25% F 7% C-
Dividend Return 2.53% 100% F 50% F
Total Return -23.92% 25% F 8% B-
Trailing 12 Months  
Capital Gain -18.58% 25% F 10% F
Dividend Return 3.65% 100% F 51% F
Total Return -14.93% 25% F 10% F
Trailing 5 Years  
Capital Gain -5.70% 17% F 37% F
Dividend Return 18.05% 100% F 63% D
Total Return 12.35% 17% F 38% F
Average Annual (5 Year Horizon)  
Capital Gain 3.24% 25% F 50% F
Dividend Return 6.02% 38% F 51% F
Total Return 2.78% 100% F 57% F
Risk Return Profile  
Volatility (Standard Deviation) 26.28% 25% F 39% F
Risk Adjusted Return 22.91% 13% F 41% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector